Most XP-F patients have mild XP symptoms and a reduced level of nuclear XPF protein since most mutations promote XPF-ERCC1 mislocalization to the cytoplasm of cells and lead to insufficient levels of XPF-ERCC1 to complete NER [23]. Here, ERCC4 is linked to Xeroderma pigmentosum complementation group F.